{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:00:13Z","timestamp":1791302413451,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior","doi-asserted-by":"publisher","award":["311940\/2018-00 \\u2013 UFPE"],"award-info":[{"award-number":["311940\/2018-00 \\u2013 UFPE"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior","doi-asserted-by":"publisher","award":["88887"],"award-info":[{"award-number":["88887"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024037","name":"Cochin Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico","doi-asserted-by":"publisher","award":["306798\/2020-4"],"award-info":[{"award-number":["306798\/2020-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico","doi-asserted-by":"publisher","award":["200827\/2020-0"],"award-info":[{"award-number":["200827\/2020-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.intimp.2024.112344","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T05:31:20Z","timestamp":1717392680000},"page":"112344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IBPA a mutual prodrug of ibuprofen and acetaminophen alleviates inflammation, immune dysregulation and fibrosis in preclinical models of systemic sclerosis"],"prefix":"10.1016","volume":"136","author":[{"given":"Anderson","family":"Rodrigues de Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Jaime Bezerra Mendon\u00e7a Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Tavares Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Eduarda de Oliveira Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Ch\u00eane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Jeljeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Chouzenoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edlian","family":"David de Azevedo Valadares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Andreza Bezerra Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Widarlane","family":"\u00c2ngela da Silva Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Carvalho Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludivine","family":"Doridot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moacyr","family":"Jesus Barreto de Melo R\u00eago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelly","family":"Cristiny Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Luzia Branco Pinto Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulcineia","family":"Saes Parra Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Nicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Batteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"Galdino da Rocha Pitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112344_b0005","article-title":"Systemic sclerosis: recent insight in clinical management","author":"Zanatta","year":"2019","journal-title":"Joint. Bone. Spine."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.112344_b0010","first-page":"3","article-title":"One year in review 2019: systemic sclerosis","volume":"37","author":"Barsotti","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112344_b0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5114\/reum.2019.87619","article-title":"Systemic sclerosis \u2013 multidisciplinary disease: clinical features and treatment","volume":"57","author":"Sobolewski","year":"2019","journal-title":"Reumatologia\/rheumatology."},{"key":"10.1016\/j.intimp.2024.112344_b0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.patbio.2015.03.003","article-title":"Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis","volume":"63","author":"Hua-Huy","year":"2015","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.intimp.2024.112344_b0025","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.medcli.2014.12.016","article-title":"Large vessels vasculopathy in systemic sclerosis","volume":"145","author":"Tejera Segura","year":"2015","journal-title":"Med Clin."},{"key":"10.1016\/j.intimp.2024.112344_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.01177","article-title":"The role of oxidative stress in the development of systemic sclerosis related vasculopathy","volume":"9","author":"Abdulle","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2024.112344_b0035","article-title":"Exosomes in Systemic Sclerosis : Messengers Between Immune","author":"Colletti","year":"2019","journal-title":"Vascular and Fibrotic Components ?"},{"key":"10.1016\/j.intimp.2024.112344_b0040","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4569826","article-title":"Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast","volume":"2019","author":"Sierra-Sep\u00falveda","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2024.112344_b0045","first-page":"310","author":"Brown","year":"2018","journal-title":"The Immunopathogenesis of Fibrosis in Systemic Sclerosis"},{"key":"10.1016\/j.intimp.2024.112344_b0050","first-page":"594","volume":"30","author":"Fuschiotti","year":"2018","journal-title":"O PINION T Cells and Cytokines in Systemic Sclerosis"},{"key":"10.1016\/j.intimp.2024.112344_b0055","article-title":"Chemokines in systemic sclerosis","author":"King","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2024.112344_b0060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor \u03b2- At the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112344_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.01985","article-title":"A potential link between oxidative stress and endothelial-to-mesenchymal transition in systemic sclerosis","volume":"9","author":"Thuan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112344_b0070","doi-asserted-by":"crossref","unstructured":"D.R. Pearson, V.P. Werth, L. Pappas-taffer, Systemic sclerosis - current concepts of skin and systemic manifestations, (2018) #pagerange#. doi: 10.1016\/j.clindermatol.2018.04.004.","DOI":"10.1016\/j.clindermatol.2018.04.004"},{"key":"10.1016\/j.intimp.2024.112344_b0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41584-018-0062-0","article-title":"Major lung complications of systemic sclerosis","volume":"14","author":"Denton","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112344_b0080","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Supplemental - Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.intimp.2024.112344_b0085","doi-asserted-by":"crossref","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases","author":"Ivasiv","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.intimp.2024.112344_b0090","article-title":"Hybrid Compounds as Direct Multitarget Ligands: A Review","author":"Oliveira Pedrosa","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.intimp.2024.112344_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113072","article-title":"Synergistic effects of curcumin and its analogs with other bioactive compounds: A comprehensive review","volume":"210","author":"Hosseini-Zare","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2024.112344_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/ph4111450","article-title":"Anti-inflammatory drug design using a molecular hybridization approach","author":"Bosquesi","year":"2011","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.intimp.2024.112344_b0105","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cvsm.2019.07.009","article-title":"Antiinflammatory Drugs","volume":"49","author":"Monteiro","year":"2019","journal-title":"Vet. Clin. North Am. - Small Anim. Pract."},{"key":"10.1016\/j.intimp.2024.112344_b0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.iac.2016.06.001","article-title":"An Overview of Nonsteroidal Antiinflammatory Drug Reactions","volume":"36","author":"Walters","year":"2016","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.intimp.2024.112344_b0115","unstructured":"V.T.H. Ngo, T. Bajaj, Ibuprofen, in: Treasure Island (FL), 2019."},{"key":"10.1016\/j.intimp.2024.112344_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1440-1681.13392","article-title":"Paracetamol \u2013 An old drug with new mechanisms of action","volume":"48","author":"Przyby\u0142a","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.intimp.2024.112344_b0125","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1590\/S1806-37132013000600008","article-title":"Immunohistochemical and morphometric evaluation of COX 1 and COX-2 in the remodeled lung in idiopathic pulmonary fibrosis and systemic sclerosis","volume":"39","author":"Parra","year":"2013","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.intimp.2024.112344_b0130","first-page":"3783","volume":"52","author":"Kowal-bielecka","year":"2005","journal-title":"Cyclooxygenase- and Lipoxygenase-Derived Eicosanoids in Bronchoalveolar Lavage Fluid from Patients with Scleroderma Lung Disease an Imbalance between Proinflammatory and Antiinflammatory Lipid Mediators"},{"key":"10.1016\/j.intimp.2024.112344_b0135","doi-asserted-by":"crossref","unstructured":"I.H. Bassyouni, R.M. Talaat, T.A. Salem, Serum Concentrations of Cyclooxygenase-2 in Patients with Systemic Sclerosis\u00a0: Association with Lower Frequency of Pulmonary Fibrosis, (2012) 124\u2013130. doi: 10.1007\/s10875-011-9601-z.","DOI":"10.1007\/s10875-011-9601-z"},{"key":"10.1016\/j.intimp.2024.112344_b0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bcp.2018.08.022","article-title":"The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders","volume":"157","author":"del R\u00edo","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112344_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13636-x","article-title":"Trained immunity modulates inflammation-induced fibrosis","volume":"10","author":"Jeljeli","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112344_b0150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112344_b0155","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112344_b0160","doi-asserted-by":"crossref","unstructured":"A.R. de Almeida, A.T. Dantas, M.C. Pereira, M.F. Cordeiro, R.S.G. Gon\u00e7alves, M.J.B. de Melo R\u00eago, I. da Rocha Pitta, A.L.B.P. Duarte, M.G. da Rocha Pitta, Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients, Inflammopharmacology. (2019). doi: 10.1007\/s10787-019-00600-w.","DOI":"10.1007\/s10787-019-00600-w"},{"key":"10.1016\/j.intimp.2024.112344_b0165","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/art.34534","article-title":"Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis","volume":"64","author":"Kavian","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112344_b0170","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0003-9861(61)90291-0","article-title":"The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid","volume":"93","author":"Woessner","year":"1961","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.intimp.2024.112344_b0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/17518253.2012.657251","article-title":"TFAA-H3PO4 mediated rapid and single-step synthesis of mutual prodrugs of paracetamol and NSAIDs","volume":"5","author":"Kankanala","year":"2012","journal-title":"Green Chem. Lett. Rev."},{"key":"10.1016\/j.intimp.2024.112344_b0180","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.biopha.2018.02.122","article-title":"Synthesis and antinociceptive evaluation of bioisosteres and hybrids of naproxen, ibuprofen and paracetamol","volume":"101","author":"Gonz\u00e1lez-Trujano","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.112344_b0185","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9817502","article-title":"Anti-Inflammatory and Anticoagulant Activities of Synthesized NSAID Prodrug Esters","author":"Abualhasan","year":"2020","journal-title":"Scientifica (cairo)"},{"key":"10.1016\/j.intimp.2024.112344_b0190","doi-asserted-by":"crossref","unstructured":"M. de Oliveira Pedrosa Rolim, A.R. de Almeida, M.G. da Rocha Pitta, M.J.B. de Melo R\u00eago, L.J. Quintans-J\u00fanior, J. de Souza Siqueira Quintans, L. Heimfarth, L. Scotti, M.T. Scotti, R.M.D. da Cruz, R.N. de Almeida, T.G. da Silva, J.A. de Oliveira, M.L. de Campos, P. Marchand, F.J.B. Mendon\u00e7a-Junior, Design, synthesis and pharmacological evaluation of CVIB, a codrug of carvacrol and ibuprofen as a novel anti-inflammatory agent., Int. Immunopharmacol. 76 (2019) 105856. doi: 10.1016\/j.intimp.2019.105856.","DOI":"10.1016\/j.intimp.2019.105856"},{"key":"10.1016\/j.intimp.2024.112344_b0195","article-title":"Development of Phenothiazine Hybrids with Potential Medicinal Interest","author":"Posso","year":"2022","journal-title":"A Review"},{"key":"10.1016\/j.intimp.2024.112344_b0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/03639045.2017.1391838","article-title":"Formulation and delivery strategies of ibuprofen: challenges and opportunities","volume":"44","author":"Irvine","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.intimp.2024.112344_b0205","article-title":"Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis","volume":"2019","author":"Lands","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2024.112344_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0249687","article-title":"Fibrotic expression profile analysis reveals repurposed drugs with potential anti-fibrotic mode of action","volume":"16","author":"Karatzas","year":"2021","journal-title":"PLoS One."},{"key":"10.1016\/j.intimp.2024.112344_b0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12325-019-01144-9","article-title":"Ibuprofen Safety at the Golden Anniversary: Are all NSAIDs the Same? A Narrative Review","volume":"37","author":"Varrassi","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.intimp.2024.112344_b0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/11596670-000000000-00000","article-title":"Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors: A focus on ketoprofen\/omeprazole","volume":"32","author":"Gigante","year":"2012","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.intimp.2024.112344_b0225","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010107.pub2","article-title":"Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain (Review)","volume":"2013","author":"Derry","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2024.112344_b0230","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ebch.1978","article-title":"Combined and alternating paracetamol and ibuprofen therapy for febrile children","volume":"9","author":"Wong","year":"2014","journal-title":"Evidence-Based Child Heal."},{"key":"10.1016\/j.intimp.2024.112344_b0235","first-page":"1","article-title":"Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action","volume":"00","author":"Ayoub","year":"2021","journal-title":"Temperature."},{"key":"10.1016\/j.intimp.2024.112344_b0240","doi-asserted-by":"crossref","unstructured":"M.N. Abualhasan, M.Y. Al-Masri, R. Manasara, L. Yadak, N.S. Abu-Hasan, Anti-Inflammatory and Anticoagulant Activities of Synthesized NSAID Prodrug Esters., Scientifica (Cairo). 2020 (2020) 9817502. doi: 10.1155\/2020\/9817502.","DOI":"10.1155\/2020\/9817502"},{"key":"10.1016\/j.intimp.2024.112344_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112344_b0250","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","article-title":"Early T cell activation in the skin from patients with systemic sclerosis","volume":"64","author":"Kalogerou","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112344_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00496","article-title":"Systemic sclerosis patients present alterations in the expression of molecules involved in B-cell regulation","volume":"6","author":"Soto","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112344_b0260","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2147\/DDDT.S288369","article-title":"The effect of nintedanib on t-cell activation, subsets and functions","volume":"15","author":"Ubieta","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2024.112344_b0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cytogfr.2015.12.002","article-title":"New insights into CD4+T cell abnormalities in systemic sclerosis","volume":"28","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2024.112344_b0270","first-page":"1540","author":"Reilly","year":"2012","journal-title":"Review T Cells in Systemic Sclerosis : a Reappraisal"},{"key":"10.1016\/j.intimp.2024.112344_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154799","article-title":"Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis","volume":"125","author":"Gasparini","year":"2020","journal-title":"Cytokine."},{"key":"10.1016\/j.intimp.2024.112344_b0280","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00281-015-0511-7","article-title":"Cytokines in the immunopathology of systemic sclerosis","volume":"37","author":"Raja","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2024.112344_b0285","article-title":"IL-17, IL-6 and IFN-\u03b3 in systemic sclerosis patients","volume":"53","author":"B\u0103l\u0103nescu","year":"2015","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.intimp.2024.112344_b0290","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/imt.13.173","article-title":"Potential use of TNF-\u03b1 inhibitors in systemic sclerosis","volume":"6","author":"Murdaca","year":"2014","journal-title":"Immunotherapy."},{"key":"10.1016\/j.intimp.2024.112344_b0295","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1136\/annrheumdis-2015-208213","article-title":"Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis","volume":"75","author":"Ponsoye","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112344_b0300","doi-asserted-by":"crossref","unstructured":"D. Khanna, C. Spino, S. Johnson, L. Chung, M.L. Whitfield, C.P. Denton, V. Berrocal, J. Franks, B. Mehta, J. Molitor, V.D. Steen, R. Lafyatis, R.W. Simms, A. Gill, S. Kafaja, T.M. Frech, V. Hsu, R.T. Domsic, J.E. Pope, J.K. Gordon, M.D. Mayes, E. Schiopu, A. Young, N. Sandorfi, J. Park, F.N. Hant, E.J. Bernstein, S. Chatterjee, F. V Castelino, A. Ajam, Y. Wang, T. Wood, Y. Allanore, M. Matucci-Cerinic, O. Distler, O. Singer, E. Bush, D.A. Fox, D.E. Furst, Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial., Arthritis Rheumatol. (Hoboken, N.J.). 72 (2020) 125\u2013136. doi: 10.1002\/art.41055.","DOI":"10.1002\/art.41055"},{"key":"10.1016\/j.intimp.2024.112344_b0305","doi-asserted-by":"crossref","unstructured":"C. Orvain, A. Cauvet, A. Prudent, C. Guignabert, R. Thuillet, M. Ottaviani, L. Tu, F. Duhalde, C. Nicco, F. Batteux, J. Avouac, N. Wang, M.A. Seaberg, S.R. Dillon, Y. Allanore, Acazicolcept (ALPN-101), a dual ICOS \/ CD28 antagonist , demonstrates efficacy in systemic sclerosis preclinical mouse models, (2022) 1\u201316. doi: 10.1186\/s13075-021-02709-2.","DOI":"10.1186\/s13075-021-02709-2"},{"key":"10.1016\/j.intimp.2024.112344_b0310","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s10067-021-05665-z","article-title":"B cells in systemic sclerosis: from pathophysiology to treatment","volume":"40","author":"Melissaropoulos","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112344_b0315","doi-asserted-by":"crossref","DOI":"10.1186\/ar4392","article-title":"B cells tell scleroderma fibroblasts to produce collagen","volume":"15","author":"Daoussis","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.112344_b0320","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/art.22847","article-title":"B cell infiltration in systemic sclerosis-associated interstitial lung disease","volume":"56","author":"Lafyatis","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112344_b0325","first-page":"1078","volume":"69","author":"Dumoitier","year":"2017","journal-title":"Scleroderma Peripheral B Lymphocytes Secrete Interleukin-6 and Transforming Growth Factor \u03b2 and Activate Fibroblasts., Arthritis Rheumatol"},{"key":"10.1016\/j.intimp.2024.112344_b0330","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/cimm.2000.1687","article-title":"Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts","volume":"204","author":"Song","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2024.112344_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.112344_b0340","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of Interferon- and transforming growth factor \u03b2-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheumatol. (hoboken, N.J.)"},{"key":"10.1016\/j.intimp.2024.112344_b0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1155\/2018\/8509583","article-title":"Soluble CD163 as a potential biomarker in systemic sclerosis","volume":"2018","author":"Frantz","year":"2018","journal-title":"Dis. Markers."},{"key":"10.1016\/j.intimp.2024.112344_b0350","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-019-0831-z","article-title":"Macrophages in Systemic Sclerosis: Novel Insights and Therapeutic Implications","volume":"21","author":"Toledo","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.intimp.2024.112344_b0355","doi-asserted-by":"crossref","first-page":"H906","DOI":"10.1152\/ajpheart.00821.2014","article-title":"M2 macrophage accumulation in the aortic wall during angiotensin ii infusion in mice is associated with fibrosis, elastin loss, and elevated blood pressure","volume":"309","author":"Moore","year":"2015","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"10.1016\/j.intimp.2024.112344_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.202012034","article-title":"Reprogramming of profibrotic macrophages for treatment of bleomycin-induced pulmonary fibrosis","volume":"12","author":"Zhang","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2024.112344_b0365","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2024.112344_b0370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2019.02.010","article-title":"Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis","volume":"209","author":"Korman","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.intimp.2024.112344_b0375","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/exd.14193","article-title":"Cellular and molecular mechanisms in fibrosis","volume":"30","author":"Dees","year":"2021","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2024.112344_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-018-1534-y","article-title":"Blockade of TGF-\u03b2\/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis","volume":"20","author":"Luong","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.112344_b0385","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2017.03.035","article-title":"Leflunomide prevents ROS-induced systemic fibrosis in mice","volume":"108","author":"Morin","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2024.112344_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.02571","article-title":"Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells","volume":"9","author":"Maria","year":"2018","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924008646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924008646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:41:57Z","timestamp":1791301317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924008646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":78,"alternative-id":["S1567576924008646"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112344","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IBPA a mutual prodrug of ibuprofen and acetaminophen alleviates inflammation, immune dysregulation and fibrosis in preclinical models of systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112344"}}